Skip to main content

Table 1 Identification results of differential metabolites and their change trends

From: Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat

No.

RT(min)

m/z

Formula

Metabolite

VIP

M vs. C

Y vs. M

CL vs. M

CM vs. M

CH vs. M

1

5.5875

898.7862

C57H100O6

TG(18:2/18:1/18:2)

2.75

↑**

–

–

↓#

↓##

2

8.9231

931.7526

C55H92O6

TG(20:4/14:0/18:3)

2.55

↑**

–

–

–

–

3

8.4467

925.7098

C48H92NO8P

PC(24:1/16:1)

2.54

↑**

–

–

↓#

–

4

2.6081

496.3364

C50H94NO8P

PC(24:1/18:2)

2.43

↑**

–

–

↓##

↓#

5

9.0509

264.9627

C41H82NO8P

PC(15:0/18:0)

2.29

↑**

–

–

↓#

–

6

9.0937

326.9082

C54H102NO8P

PC(24:1/22:2)

2.70

↑**

↓##

–

↓##

↓##

7

1.8681

516.3129

C24H48NO7P

LPC(16:1/0:0)

2.35

↑**

–

–

–

–

8

2.0389

610.3188

C30H54NO7P

LPC(22:4/0:0)

2.56

↑**

–

↓#

–

–

9

2.0460

542.3279

C26H50NO7P

LPC(18:2/0:0)

2.37

↑**

–

↓##

–

–

10

4.1085

273.6606

C26H54NO7P

LPC(18:0/0:0)

2.09

↑*

–

–

–

–

11

9.3573

416.2983

C45H76NO8P

PE(18:3/22:4)

2.15

↑**

–

–

↓#

↓#

12

9.0937

326.9082

C53H102NO8P

PE(24:1/24:1)

2.43

↑*

–

–

↓##

↓##

13

9.0230

376.8943

C51H90O2

CE(24:1)

2.60

↑*

↓#

–

↓##

↓##

  1. C, control group; M, model group; Y, benzbromarone group; CL, low dosage group; CM, medium dosage group; CH, high dosage group; **, p < 0.01 vs. control group. *, p < 0.05 vs. control group; ##, p < 0.01 vs. model group; #, p < 0.05 vs. model group. (↑): up-regulated and (↓): down-regulated. (−):no statistically significant difference